The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Loss of B-cell translocation gene 2 in estrogen receptor–positive breast cancer and tamoxifen resistance.
T. Hayashida
No relevant relationships to disclose
H. Jinno
No relevant relationships to disclose
M. Takahashi
No relevant relationships to disclose
Y. Kitagawa
No relevant relationships to disclose